Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|October 8, 2024
Role of <sup>18</sup>F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?Nina Jehanno, Nadège Corradini, Nathalie Gaspar, et al.
Antiviral Research|February 7, 2017
Strategies for serum chemokine/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseasesErica Godinho Menezes, Jordana Grazziela Alves Coelho-Dos-Reis, Ludmila Melo Cardoso, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Optimal duration of adjuvant chemotherapy for high-risk node-negative (N-) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)Pierre Kerbrat, Isabelle Desmoulins, Lise Roca, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma GroupAxel Le Cesne, Isabelle Ray-Coquard, Florence Duffaud, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2013
Primary cardiac sarcomas: a retrospective study of the French Sarcoma GroupNicolas Isambert, Isabelle Ray-Coquard, Antoine Italiano, et al.
International Journal of Cancer|June 28, 2019
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 studySophie Piperno-Neumann, Isabelle Ray-Coquard, Bob-Valéry Occean, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2016
Management of desmoid tumours: A nationwide survey of labelled reference centre networks in FranceNicolas Penel, Jean-Michel Coindre, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETOJean-Yves Blay, Nicolas Penel, Maud Toulmonde, et al.
Cancer Medicine|June 30, 2018
Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide studyEmmanuelle Bompas, Loïc Campion, Antoine Italiano, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2019
UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroupVéronique D'Hondt, Jean-Luc Canon, Lise Roca, et al.
Pageof 15